29 March 2018
Presentations to feature progress on Lyme and Zika vaccine candidates
Valneva SE (“Valneva” or “the Company”), a fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines, announces today that it will present on its Lyme disease and Zika vaccine candidates on April 4, 2018 at the 18th World Vaccine Congress in Washington, D.C. Over 800 vaccine specialists will attend the event.